Cargando…
Cancer immune exclusion: breaking the barricade for a successful immunotherapy
Immunotherapy has changed the course of cancer treatment. The initial steps were made through tumor-specific antibodies that guided the setup of an antitumor immune response. A new and successful generation of antibodies are designed to target immune checkpoint molecules aimed to reinvigorate the an...
Autores principales: | Bruni, Sofia, Mercogliano, María Florencia, Mauro, Florencia Luciana, Cordo Russo, Rosalia Inés, Schillaci, Roxana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239871/ https://www.ncbi.nlm.nih.gov/pubmed/37284199 http://dx.doi.org/10.3389/fonc.2023.1135456 |
Ejemplares similares
-
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
por: Mercogliano, María Florencia, et al.
Publicado: (2021) -
ODP438 Canonical and Non-canonical Function of EZH2 in Progesterone Receptor Target Genes in Breast Cancer
por: Elizalde, Patricia, et al.
Publicado: (2022) -
Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2020) -
Emerging Targeted Therapies for HER2-Positive Breast Cancer
por: Mercogliano, María Florencia, et al.
Publicado: (2023) -
ODP551 Halting ErbB-2 Isoforms Retrograde Transport to the Nucleus as a New Theragnostic Approach for Triple Negative Breast Cancer
por: Elizalde, Patricia Virginia, et al.
Publicado: (2022)